Related Experiment Video
Updated: Apr 16, 2026

Anti-Nuclear Antibody Screening Using HEp-2 Cells
Published on: June 23, 2014
Atherosclerotic vascular disease in the autoimmune rheumatologic patient
1Division of Cardiovascular Diseases, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA, mankad.rekha@mayo.edu.
Insights
Autoimmune diseases significantly increase the risk of atherosclerotic cardiovascular diseases (ASCVD), especially in women. Recognizing this link and inflammation
Area of Science:
- Rheumatology
- Immunology
- Cardiology
Background:
- Autoimmune diseases like rheumatoid arthritis and lupus are linked to higher atherosclerotic cardiovascular diseases (ASCVD) risk.
- Women are disproportionately affected by autoimmune conditions and have higher cardiovascular mortality, highlighting a critical gender-specific risk.
- Inflammation and immune dysregulation are shared mechanisms underlying both autoimmune conditions and atherosclerosis.
Purpose of the Study:
- To explore the heightened cardiovascular risk in patients with autoimmune diseases.
- To investigate the role of inflammation and immune mechanisms in ASCVD development within this population.
- To address the under-recognition of cardiovascular risk in autoimmune patients and the limitations of current risk assessment tools.
Main Methods:
- Literature review and synthesis of existing research on autoimmune diseases and cardiovascular outcomes.
- Analysis of the interplay between inflammatory pathways, immune responses, and atherogenesis.
- Examination of the performance of traditional cardiovascular risk algorithms in autoimmune populations.
Main Results:
- Autoimmune diseases are associated with a substantially increased risk of ischemic heart disease (IHD) and other ASCVDs.
- Current cardiovascular risk prediction models inadequately capture the elevated risk in patients with autoimmune conditions.
- Inflammation is a key driver of atherosclerosis in autoimmune disease, contributing to cardiovascular risk beyond traditional factors.
Conclusions:
- There is a critical need to improve awareness and recognition of elevated cardiovascular risk among autoimmune patients and healthcare providers.
- Novel risk assessment strategies incorporating inflammatory markers are needed for the autoimmune population.
- Understanding the shared inflammatory pathways is crucial for developing targeted prevention and treatment strategies for cardiovascular disease in autoimmune conditions.
Abstract:
Autoimmune diseases, such as rheumatoid arthritis and systemic lupus erythematosus, have a strong association with an increased risk of atherosclerotic cardiovascular diseases (ASCVD), particularly ischemic heart disease (IHD). A majority of the autoimmune conditions occur predominantly in women, and as women continue to experience a higher cardiovascular mortality compared to men, this potential added risk factor must be recognized. Inflammation and immune mechanisms have been shown to be an underlying mechanism for the development of atherosclerosis, thus sharing a common mechanism with rheumatologic conditions. There is an under recognition, in both patient and physician, of the increased cardiovascular (CV) risk within the autoimmune population, with present CV risk profile algorithms performing poorly in these patients. Traditional risk factors play a role in the development of IHD in the autoimmune patient, but their overall significance is unclear and does not fully explain the elevated CV risk. The role of inflammation and risk factors in autoimmune conditions, and their link to the elevated CV risk will be explored within this article.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Atherosclerosis I: Introduction
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis III: Management
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

